| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016800 |
| Receipt No. | R000019371 |
| Official scientific title of the study | Investigation into safety of preoperative oral intake of carbohydrate rich beverage in diabetic patients. Part2 |
| Date of disclosure of the study information | 2015/03/31 |
| Last modified on | 2018/03/18 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Investigation into safety of preoperative oral intake of carbohydrate rich beverage in diabetic patients. Part2 | |
| Title of the study (Brief title) | Preoperative oral intake of carbohydrate rich beverage in diabetic patients. Pert2 | |
| Region |
|
|
| Condition | ||
| Condition | Diabetic patients undergoing surgery with general anesthesia | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | They say preoperative oral intake of carbohydrate rich beverage improves preoperative thirst, hunger and insulin resistance. But in diabetic patients hyperglycemia induced by oral intake of carbohydrate rich beverage was concerned. And so we examined the safety of preoperative oral intake of carbohydrate rich beverage in diabetic patients. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Blood glucose level after induction of anesthesia. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Group A: Type 2 diabetes patients were not permitted to take solid food from 2100 hours the day before surgery, permitted to drink clear fluid and encouraged to drink carbohydrate rich beverage (Arginaid Water) until 700 hours the day of surgery. After induction of general anesthesia, radial arterial catheter was inserted and blood gas analysis was done.
From September 2012 to April 2014, Data were collected in the study registered UMIN000011266. |
|
| Interventions/Control_2 | Group C: Type 2 diabetes patients were not permitted to take solid food from 2100 hours the day before surgery, permitted to drink clear fluid. After induction of general anesthesia, radial arterial catheter was inserted and blood gas analysis was done. From January 2011 to September 2012, data were collected in medical records retrospectively. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with type 2 diabetes mellitus who underwent surgery with general anesthesia entering the operating room at 845 hours.
|
|||
| Key exclusion criteria | Type 1 diabetes mellitus
Final stage of a terminal illness Untreated diabetes Uncontrolled diabetes Unconsciousness Emergency surgeries Cardiac surgeries |
|||
| Target sample size | 54 | |||
| Research contact person | |
| Name of lead principal investigator | Motoi Sasuga |
| Organization | Tokyo Metropolitan Tama Medical Center |
| Division name | Department of anesthesiology |
| Address | 2-8-29 Musashidai, Fuchu, Tokyo 183-8524, Japan |
| TEL | 042-323-5111 |
| motoi_sasuga@tmhp.jp | |
| Public contact | |
| Name of contact person | Motoi Sasuga |
| Organization | Tokyo Metropolitan Tama Medical Center |
| Division name | Department of anesthesiology |
| Address | 2-8-29 Musashidai, Fuchu, Tokyo 183-8524, Japan |
| TEL | 042-323-5111 |
| Homepage URL | |
| motoi_sasuga@tmhp.jp | |
| Sponsor | |
| Institute | Department of anesthesiology, Tokyo Metropolitan Tama Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019371 |